Chugai Venture Fund
Boston, Massachusetts, United StatesFounded 2023
Chugai Venture Fund (CVF) is the corporate venture capital arm of Chugai Pharmaceutical Co., Ltd., headquartered in Boston, MA. It invests primarily in early-stage drug discovery and life sciences start-ups to accelerate innovation and expand Chugai's R&D capabilities.
88% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $56.3M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
$200M
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ten63 | Unknown | — | Feb 2026 |
| DDualitas | Series A | $65M | Sep 2025 |
 Dualitas Therapeutics | Series A | $65M | Sep 2025 |
 Stylus Medicine | Series A | $45M | May 2025 |
| Dualitas Therapeutics | Series A | $65M | Jan 2025 |
 HYKU Biosciences | Seed | $64M | Nov 2024 |
 Leal Therapeutics | Series B | $45M | Oct 2024 |
| Leal Therapeutics | Seed | $45M | Jan 2024 |
Top Co-Investors
Alexandria Venture Investments6 shared
Eli Lilly and Company4 shared
Qiming Venture Partners USA3 shared
SV Health Investors3 shared
Versant Ventures3 shared
Euclidean Capital2 shared
OrbiMed2 shared
Newpath Partners2 shared
RA Capital Management2 shared
Morpheus Ventures1 shared
Gates Foundation1 shared
Yosemite1 shared
Terra Venture Partners1 shared
Duke Capital Partners1 shared
K5 Global1 shared
Draper Associates1 shared
Black Opal Ventures1 shared
Brainstorm Ventures1 shared
Khosla Ventures1 shared
Novartis Venture Fund1 shared
Last updated: 7 October 2026